Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney loop of Henle epithelial cell | 8 studies | 48% ± 20% | |
renal alpha-intercalated cell | 7 studies | 79% ± 10% | |
epithelial cell | 7 studies | 48% ± 21% | |
astrocyte | 7 studies | 20% ± 4% | |
goblet cell | 6 studies | 34% ± 23% | |
kidney connecting tubule epithelial cell | 5 studies | 74% ± 15% | |
kidney distal convoluted tubule epithelial cell | 5 studies | 84% ± 13% | |
renal principal cell | 5 studies | 43% ± 15% | |
basal cell | 4 studies | 29% ± 9% | |
renal beta-intercalated cell | 4 studies | 97% ± 1% | |
abnormal cell | 4 studies | 43% ± 27% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 31% ± 5% | |
epithelial cell of proximal tubule | 4 studies | 23% ± 8% | |
secretory cell | 3 studies | 22% ± 5% | |
fibroblast | 3 studies | 31% ± 11% | |
keratinocyte | 3 studies | 38% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 6 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 42432.85 | 89 / 89 | 92% | 335.70 | 825 / 901 |
breast | 64% | 3765.07 | 292 / 459 | 79% | 252.06 | 883 / 1118 |
pancreas | 95% | 6613.04 | 313 / 328 | 28% | 18.94 | 49 / 178 |
uterus | 65% | 3861.98 | 110 / 170 | 55% | 52.79 | 252 / 459 |
bladder | 67% | 3845.29 | 14 / 21 | 51% | 48.76 | 257 / 504 |
esophagus | 53% | 6806.18 | 772 / 1445 | 63% | 92.58 | 116 / 183 |
skin | 100% | 19574.14 | 1809 / 1809 | 13% | 8.23 | 61 / 472 |
intestine | 46% | 6805.64 | 447 / 966 | 60% | 46.83 | 315 / 527 |
stomach | 32% | 995.03 | 115 / 359 | 38% | 24.08 | 109 / 286 |
tonsil | 0% | 0 | 0 / 0 | 56% | 65.51 | 25 / 45 |
brain | 28% | 2139.51 | 751 / 2642 | 26% | 18.68 | 184 / 705 |
lung | 10% | 366.52 | 58 / 578 | 39% | 44.01 | 455 / 1155 |
thymus | 4% | 86.00 | 23 / 653 | 32% | 33.58 | 193 / 605 |
adipose | 32% | 1401.88 | 381 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 30% | 1296.95 | 405 / 1335 | 0% | 0 | 0 / 0 |
prostate | 25% | 842.92 | 62 / 245 | 2% | 0.73 | 8 / 502 |
ovary | 1% | 28.31 | 2 / 180 | 14% | 8.14 | 62 / 430 |
lymph node | 0% | 0 | 0 / 0 | 10% | 4.16 | 3 / 29 |
liver | 1% | 28.26 | 2 / 226 | 9% | 6.91 | 36 / 406 |
eye | 0% | 0 | 0 / 0 | 6% | 7.07 | 5 / 80 |
heart | 4% | 180.32 | 34 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 2% | 1.03 | 4 / 230 |
muscle | 0% | 3.31 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 4.13 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0044849 | Biological process | estrous cycle |
GO_0055064 | Biological process | chloride ion homeostasis |
GO_0006730 | Biological process | one-carbon metabolic process |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004089 | Molecular function | carbonate dehydratase activity |
Gene name | CA12 |
Protein name | CA12 protein (cDNA FLJ20151 fis, clone COL08412) Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) Carbonic anhydrase (EC 4.2.1.1) |
Synonyms | hCG_2003428 |
Description | FUNCTION: Reversible hydration of carbon dioxide. . FUNCTION: Reversible hydration of carbon dioxide. . |
Accessions | ENST00000422263.2 Q9NXM9 ENST00000344366.7 [O43570-2] O43570 B3KUB4 ENST00000178638.8 [O43570-1] |